ArticleInternal medicine (Tokyo, Japan)2026
Evaluation of the Short-term Effect of Pemafibrate on Liver Fibrosis Biomarkers Stratified by FIB-4 Index in Patients with Type 2 Diabetes Mellitus and Hypertriglyceridemia.
Takashi Kitao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.